KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) EBT Margin (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed EBT Margin for 7 consecutive years, with 7.29% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 154.0% to 7.29% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7.1% through Dec 2025, up 312.0% year-over-year, with the annual reading at 7.1% for FY2025, 312.0% up from the prior year.
  • EBT Margin hit 7.29% in Q4 2025 for GoodRx Holdings, up from 3.11% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 9.64% in Q2 2025 to a low of 25.9% in Q3 2023.
  • Historically, EBT Margin has averaged 0.3% across 5 years, with a median of 2.35% in 2021.
  • Biggest YoY gain for EBT Margin was 20181bps in 2021; the steepest drop was -3311bps in 2021.
  • Year by year, EBT Margin stood at 2.75% in 2021, then tumbled by -194bps to 2.58% in 2022, then plummeted by -386bps to 12.53% in 2023, then soared by 146bps to 5.75% in 2024, then rose by 27bps to 7.29% in 2025.
  • Business Quant data shows EBT Margin for GDRX at 7.29% in Q4 2025, 3.11% in Q3 2025, and 9.64% in Q2 2025.